{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:00:20Z","timestamp":1773802820353,"version":"3.50.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373897"],"award-info":[{"award-number":["82373897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922069 and 81974505"],"award-info":[{"award-number":["81922069 and 81974505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic and Applied Basic Research Project of Guangzhou Basic Research Program","award":["2024A04J3325 and 2024A03J0451"],"award-info":[{"award-number":["2024A04J3325 and 2024A03J0451"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The development of BCR-ABL tyrosine kinase inhibitors has revolutionized disease management of chronic myeloid leukemia (CML). However, the persistence of leukemia stem cells (LSC) remains a major barrier to curing CML, highlighting the urgent need to identify the regulators supporting LSCs. In this study, we validated the critical role of the histone methyltransferase SET and MYND domain-containing 3 (SMYD3) in the maintenance of LSCs in CML. SMYD3 was overexpressed in CML LSCs and enhanced the survival and self-renewal properties of human primary CML CD34+ cells. Loss of SMYD3 blocked leukemogenesis and impaired the self-renewal and disease reconstitution abilities of LSCs in mice without affecting normal hematopoiesis. SMYD3 stimulated fatty acid \u03b2-oxidation (FAO) in LSCs by activating the FABP5\/PPARD\/CPT1A signaling axis in a methyltransferase activity\u2013dependent manner. Blocking CPT1A-mediated FAO reduced the function of human CML LSCs in vitro and depleted LSCs in vivo. These findings shed light on the role of histone lysine methylation\u2013mediated FAO in the maintenance of LSCs and suggest that SMYD3 may serve as a therapeutic target for treating patients with CML.<\/jats:p>\n                  <jats:p>Significance: The epigenetic modulator SMYD3 promotes leukemogenesis and self-renewal of leukemia stem cells by upregulating FABP5 to stimulate fatty acid \u03b2-oxidation, which can be targeted to treat chronic myeloid leukemia.<\/jats:p>","DOI":"10.1158\/0008-5472.can-24-2117","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:48:01Z","timestamp":1741873681000},"page":"2027-2045","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SMYD3 Activates Fatty Acid \u03b2-Oxidation to Promote Self-Renewal of Leukemia Stem Cells"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-1328","authenticated-orcid":false,"given":"Min","family":"Zhou","sequence":"first","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1289-4144","authenticated-orcid":false,"given":"Zihao","family":"Wu","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4333-3131","authenticated-orcid":false,"given":"Fen","family":"Wei","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6337-8064","authenticated-orcid":false,"given":"Chen","family":"Duan","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-2916","authenticated-orcid":false,"given":"Xiaoying","family":"Lin","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5792-8079","authenticated-orcid":false,"given":"Waiyi","family":"Zou","sequence":"additional","affiliation":[{"name":"3Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-8787","authenticated-orcid":false,"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-2947","authenticated-orcid":false,"given":"Jingxuan","family":"Pan","sequence":"additional","affiliation":[{"name":"4State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-5546","authenticated-orcid":false,"given":"Yanli","family":"Jin","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China."},{"name":"2Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"2025060203074142800_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"O'Hare","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2025060203074142800_bib2","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0140-6736(21)01204-6","article-title":"Chronic myeloid leukaemia","volume":"398","author":"Cortes","year":"2021","journal-title":"Lancet"},{"key":"2025060203074142800_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11899-022-00679-z","article-title":"Therapy resistance and disease progression in CML: mechanistic links and therapeutic strategies","volume":"17","author":"Ng","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"key":"2025060203074142800_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"2025060203074142800_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"2025060203074142800_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"2025060203074142800_bib7","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"2025060203074142800_bib8","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/s41375-022-01682-2","article-title":"Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance","volume":"36","author":"B\u00fchrer","year":"2022","journal-title":"Leukemia"},{"key":"2025060203074142800_bib9","first-page":"73","article-title":"Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option","volume":"142","author":"Dolinska","year":"2023","journal-title":"Blood"},{"key":"2025060203074142800_bib10","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.3390\/jcm10245805","article-title":"Shedding light on targeting chronic myeloid leukemia stem cells","volume":"10","author":"Houshmand","year":"2021","journal-title":"J Clin Med"},{"key":"2025060203074142800_bib11","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41467-023-40222-z","article-title":"Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells","volume":"14","author":"Rattigan","year":"2023","journal-title":"Nat Commun"},{"key":"2025060203074142800_bib12","doi-asserted-by":"crossref","first-page":"eabh3462","DOI":"10.1126\/scitranslmed.abh3462","article-title":"Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability","volume":"13","author":"Zhou","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025060203074142800_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"key":"2025060203074142800_bib14","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","article-title":"Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition","volume":"6","author":"Scott","year":"2016","journal-title":"Cancer Discov"},{"key":"2025060203074142800_bib15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/2159-8290.CD-15-1439","article-title":"Chronic myelogenous leukemia- initiating cells require polycomb group protein EZH2","volume":"6","author":"Xie","year":"2016","journal-title":"Cancer Discov"},{"key":"2025060203074142800_bib16","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1172\/JCI85239","article-title":"Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia","volume":"126","author":"Jin","year":"2016","journal-title":"J Clin Invest"},{"key":"2025060203074142800_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cmet.2022.04.004","article-title":"Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML","volume":"34","author":"Liu","year":"2022","journal-title":"Cell Metab"},{"key":"2025060203074142800_bib18","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1038\/s41388-021-01799-1","article-title":"Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6","volume":"40","author":"Zhou","year":"2021","journal-title":"Oncogene"},{"key":"2025060203074142800_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncb1151","article-title":"SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells","volume":"6","author":"Hamamoto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"2025060203074142800_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ccell.2016.01.013","article-title":"Smyd3 is a transcriptional potentiator of multiple cancer-promoting genes and required for liver and colon cancer development","volume":"29","author":"Sarris","year":"2016","journal-title":"Cancer Cell"},{"key":"2025060203074142800_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature13320","article-title":"SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer","volume":"510","author":"Mazur","year":"2014","journal-title":"Nature"},{"key":"2025060203074142800_bib22","doi-asserted-by":"crossref","first-page":"eadi5921","DOI":"10.1126\/sciadv.adi5921","article-title":"The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer","volume":"9","author":"Ikram","year":"2023","journal-title":"Sci Adv"},{"key":"2025060203074142800_bib23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/nar\/gky1221","article-title":"SMYD3 promotes the epithelial-mesenchymal transition in breast cancer","volume":"47","author":"Fenizia","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025060203074142800_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13148-023-01506-9","article-title":"Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription","volume":"15","author":"Yang","year":"2023","journal-title":"Clin Epigenetics"},{"key":"2025060203074142800_bib25","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1038\/s41467-023-41167-z","article-title":"Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"2025060203074142800_bib26","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/jcp.24975","article-title":"A SMYD3 small-molecule inhibitor impairing cancer cell growth","volume":"230","author":"Peserico","year":"2015","journal-title":"J Cell Physiol"},{"key":"2025060203074142800_bib27","doi-asserted-by":"crossref","first-page":"103628","DOI":"10.1016\/j.drudis.2023.103628","article-title":"The emerging role of fatty acid binding protein 5 (FABP5) in cancers","volume":"28","author":"George Warren","year":"2023","journal-title":"Drug Discov Today"},{"key":"2025060203074142800_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1947601913499155","article-title":"A novel cutaneous fatty acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells","volume":"4","author":"Bao","year":"2013","journal-title":"Genes Cancer"},{"key":"2025060203074142800_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function","volume":"31","author":"Field","year":"2020","journal-title":"Cell Metab"},{"key":"2025060203074142800_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2025060203074142800_bib31","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3390\/cells11152432","article-title":"Peroxisome proliferator-activated receptors and the hallmarks of cancer","volume":"11","author":"Wagner","year":"2022","journal-title":"Cells"},{"key":"2025060203074142800_bib32","doi-asserted-by":"crossref","first-page":"109212","DOI":"10.1016\/j.celrep.2021.109212","article-title":"High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity","volume":"35","author":"Mana","year":"2021","journal-title":"Cell Rep"},{"key":"2025060203074142800_bib33","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1158\/1078-0432.CCR-16-0775","article-title":"Molecular pathways: dietary regulation of stemness and tumor initiation by the PPAR-\u03b4 Pathway","volume":"22","author":"Beyaz","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2025060203074142800_bib34","doi-asserted-by":"crossref","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"2025060203074142800_bib35","first-page":"4480","article-title":"PPAR\u03b4 mediates the effect of dietary fat in promoting colorectal cancer metastasis","volume":"79","author":"Wang","year":"2019","journal-title":"Cancer Res"},{"key":"2025060203074142800_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.003","article-title":"SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance","volume":"430","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"2025060203074142800_bib37","first-page":"6008","article-title":"Jagged2 promotes cancer stem cell properties of triple negative breast cancer cells and paclitaxel resistance via regulating microRNA-200","volume":"22","author":"Li","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025060203074142800_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41420-021-00508-x","article-title":"ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling","volume":"7","author":"Zhu","year":"2021","journal-title":"Cell Death Discov"},{"key":"2025060203074142800_bib39","doi-asserted-by":"crossref","first-page":"e2404476","DOI":"10.1002\/advs.202404476","article-title":"Super-enhancer driven LIF\/LIFR-STAT3-SOX2 regulatory feedback loop promotes cancer stemness in head and neck squamous cell carcinoma","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"2025060203074142800_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41420-024-01839-1","article-title":"Targeting metastasis-initiating cancer stem cells in gastric cancer with leukaemia inhibitory factor","volume":"10","author":"Seeneevassen","year":"2024","journal-title":"Cell Death Discov"},{"key":"2025060203074142800_bib41","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/cancers13122863","article-title":"Podocalyxin in normal tissue and epithelial cancer","volume":"13","author":"Le Tran","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025060203074142800_bib42","first-page":"30375","article-title":"FABP5 as a novel molecular target in prostate cancer","volume":"S1359-6446","author":"O'Sullivan","year":"2020","journal-title":"Drug Discov Today"},{"key":"2025060203074142800_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41419-020-02936-6","article-title":"Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer","volume":"11","author":"Xiong","year":"2020","journal-title":"Cell Death Dis"},{"key":"2025060203074142800_bib44","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","article-title":"N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"2025060203074142800_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/stem.3101","article-title":"Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells","volume":"38","author":"Visweswaran","year":"2020","journal-title":"Stem Cells"},{"key":"2025060203074142800_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-018-0784-5","article-title":"Emerging role of lipid metabolism alterations in Cancer stem cells","volume":"37","author":"Yi","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"2025060203074142800_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab"},{"key":"2025060203074142800_bib48","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.2020008551","article-title":"Very long chain fatty acid metabolism is required in acute myeloid leukemia","volume":"137","author":"Tcheng","year":"2021","journal-title":"Blood"},{"key":"2025060203074142800_bib49","doi-asserted-by":"crossref","first-page":"1160440","DOI":"10.3389\/fphar.2023.1160440","article-title":"Mitochondrial CPT1A: insights into structure, function, and basis for drug development","volume":"14","author":"Liang","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025060203074142800_bib50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3389\/fonc.2019.01201","article-title":"CPT1A\/2-mediated FAO enhancement-a metabolic target in radioresistant breast cancer","volume":"9","author":"Han","year":"2019","journal-title":"Front Oncol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-2117\/3557353\/can-24-2117.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/11\/2027\/3608578\/can-24-2117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/11\/2027\/3608578\/can-24-2117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:07:55Z","timestamp":1748833675000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/11\/2027\/762570\/SMYD3-Activates-Fatty-Acid-Oxidation-to-Promote"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,3,13]]},"published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-2117","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.29209262","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209274","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209286","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209253","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209265","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209277","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209244","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209289","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209256","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209268","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209247","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209259","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209280","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209292","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209271","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209283","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29209250","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.7851692","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]}}}